ML22068A014
| ML22068A014 | |
| Person / Time | |
|---|---|
| Issue date: | 03/15/2022 |
| From: | Kevin Williams NRC/NMSS/DMSST |
| To: | Ellis W Board of Pharmaceutical Specialties |
| Jenny Fisher/NMSS/MSST/MSEB | |
| References | |
| Download: ML22068A014 (3) | |
Text
March 15, 2022 Board of Pharmacy Specialties ATTN: William M. Ellis, RPh, MS Executive Director 2215 Constitution Avenue, NW Washington, DC 20037-2985
SUBJECT:
BOARD OF PHARMACY SPECIALTIES, REVIEW OF SPECIALTY BOARD CONTINUED RECOGNITION BY THE U.S. NUCLEAR REGULATORY COMMISSION
Dear William M. Ellis:
I am writing to request confirmation that the Board of Pharmacy Specialties (BPS) continues to satisfy the U.S. Nuclear Regulatory Commission (NRC) recognition criteria for specialty board certification process. The NRC is reaching out to all its recognized specialty boards per the Office of Nuclear Material Safety and Safeguards (NMSS) Office Procedure1 70-3, Procedures for Recognizing, Monitoring, and Terminating the Certification Process of Specialty Boards, Section 3.1, Monitoring Continued Satisfaction of Recognition Requirements. Subsequent reviews will be performed on a 5-year basis.
As part of this review, the NRC staff will evaluate the recognized boards publicly available Web site for changes that could affect the recognition of the boards certification process. The staff will determine if the boards certification program continues to meet the applicable criteria for recognition of board certifications, as established in the NRC regulations.
To ensure that each specialty board continues to meet the NRC requirements in Title 10 of the Code of Federal Regulations (10 CFR) Part 352, Medical Use of Byproduct Material, please respond in writing within 30 days of the date of this letter and address the following:
- 1) Confirm the specialty boards current name.
- 2) Confirm the name of the specialty certification(s) or certificates.
- 3) Confirm that the specialty board still satisfies the board recognition criteria in 10 CFR 35.55, Training for an authorized nuclear pharmacist.
- 4) Confirm that there have been no changes in the boards certification procedures that could affect the recognition status.
1 The NMSS Office Procedure MSST-70-3, Procedures for Recognizing, Monitoring, and Terminating the Certification Process of Specialty Boards, is available for review at:
https://www.nrc.gov/docs/ML2035/ML20351A389.pdf.
2 The 10 CFR Part 35 index is available for review at: https://www.nrc.gov/reading-rm/doc-collections/cfr/part035/index.html.
W. Ellis 2
- 5) Confirm that the enclosed certificate is current.
The board does not need to generate any new documents to support your response. Please submit your response on official letterhead and signed (physically or electronically) by a person authorized to speak for the board (i.e., its chief executive officer or designee). Please send your letter as an e-mail attachment to the staff contacts below, and the NRC will ensure it is captured as an official record.
In accordance with 10 CFR 2.390, Public inspections, exemptions, requests for withholding, a copy of this letter, along with your response letter, will be made available electronically for public inspection in the NRC Public Document Room or in the NRCs Agencywide Documents Access and Management System, accessible from the NRC Web site at http://www.nrc.gov/reading-rm/adams.html.
For further information or for questions, please contact Maryann Ayoade at (301) 415-0862 or via e-mail at Maryann.Ayoade@nrc.gov, or Jennifer Fisher at (301) 415-1456 or via e-mail at Jennifer.Fisher@nrc.gov.
Clark, Theresa signing on behalf of Williams, Kevin on 03/15/22 Kevin Williams, Director Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards
Enclosure:
BPS Board Certified Nuclear Pharmacist Certificate (ADAMS Accession No. ML13177A354)
Ltr ML22068A014 NMSS/MSST NMSS/MSST/MSEB OFFICE NMSS/MSST/MSEB NMSS/MSST
/MSEB /MRST KWilliams NAME JFisher JF MAyoade MA CEinberg CE TClark for TC DATE Mar 9, 2022 Mar 10, 2022 Mar 10, 2022 Mar 15, 2022